MelissaAccordinoMDMS

Breast Cancer, Hematologic Oncology

Associate Professor of Medicine, Columbia University Medical Center

Overview of Dr. Accordino

Melissa Accordino, MD is a New York-based Oncologist specializing in Breast Cancer. She is an Associate Professor at NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Accordino completed her residency in Internal Medicine at New York Presbyterian Hospital and holds an MS in Patient Oriented Research from Columbia University Mailman School of Public Health. She has several publications in noted medical journals, and has been involved in clinical trials related to chemotherapy and cancer. She has received multiple awards, including the Merit Award from the Conquer Cancer Foundation of ASCO and the Young Investigator Award.

Office
161 Fort Washington Avenue
Herbert Irving Pavilion Garden Level
New York, NY 10032
Book by Phone+1(785) 289-5637

Education & Training

Columbia University Mailman School of Public HealthMS, Patient Oriented Research, 2016 - 2018
NewYork-Presbyterian/Columbia University Irving Medical Center2012 - 2015
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2009 - 2012
Pennsylvania State University College of MedicineClass of 2009
The Pennsylvania State University, University Health ServicesB.S., Premedicine, 2001 - 2004

Certifications & Licensure

NY State Medical License 2012 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Merit Award Recipient Conquer Cancer Foundation of ASCO, 2015
Chief Fellow Columbia University Medical Center, 2014-2015
Member Alpha Omega Alpha, 2008
Merit Award Winner Conquer Cancer Foundation of The American Society of Clinical Oncology (ASCO), 2015
Young Investigator Award Conquer Cancer Foundation of ASCO, 2014
Elected to Alpha Omega Alpha The Pennsylvania State University College of Medicine, 2008
Alpha Epsilon Delta Pre-Medicine Honor Society, The Pennsylvania State University, 2004
Join now to see all

Clinical Trials

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer Start of enrollment: 2018 Sep 17
Recruiting
Not Applicable
The CONTRoL Trial: Cryotherapy vs. cOmpression Neuropathy TRiaL Start of enrollment: 2019 Apr 25
Completed
Not Applicable
Glucose Monitoring During Chemotherapy Start of enrollment: 2019 Oct 31
Active, not recruiting

Publications & Presentations

PubMed

Phase I/Ib Trial of Inavolisib Plus Palbociclib and Endocrine Therapy for-Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advance...
Komal L Jhaveri, Melissa K Accordino, Philippe L Bedard, Andrés Cervantes, Valentina Gambardella
Journal of Clinical Oncology. 2024-11-20
Pharmacist-Led Video Consultation to Identify and Mitigate Drug Interactions Among Patients Initiating Oral Anticancer Drugs.
Morgan R L Lichtenstein, Peter Campbell, Rohit Raghunathan, Melissa Beauchemin, Elena B Elkin
JCO Oncology Practice. 2024-09-30
Genomic and transcriptomic landscape of HER2-low breast cancer.
Rani Bansal, Tolulope Adeyelu, Andrew Elliott, Phillip Walker, Matias A Bustos
Breast Cancer Research and Treatment. 2024-09-20

Journal Articles

Trends in use and safety of image-guided transthoracic needle biopsies in cancer patients
Accordino MK, Wright JD, Buono D, Neugut AI, Hershman DL, Journal of Oncology Practice, 1/1/2015
Cardiac Effects of Anticancer Therapy in the Elderly
Accordino MK, Neugut AI, Hershman DL, Journal of Clinical Oncology, 1/1/2014
Disparities and challenges in adherence to oral antineoplastic agents
Accordino MK, Hershman DL, American Society of Clinical Oncology Educational Book, 1/1/2013
Limited overall survival in patients with brain metastases from triple negative breast cancer
Morris PG, Murphy CG, Maliam D, Accordino M, Patil S, Howard J, Omuro A, Beal K, Seidman AD, Hudis CA, Fornier MN, Breast Journal, 1/1/2012
Does medical student knowledge of anticoagulation differ by future intended practice?
Accordino MK, Masters PA, Chuang CH, Medical Teacher, 1/1/2010
Serum Tumor Marker Utilization in Patients with Advanced Solid Tumors
Accordino, MK, Wright JD, Vasan S, Neugut AI, Tergas AI, Hu JC, Hershman DL, Journal of Oncology Practice
Join now to see all

Abstracts/Posters

Serum Tumor Marker Utilization in Patients with Advanced Solid Tumors
Accordino MK, Wright JD, Vasan S, Neugut AI, Tergas A, Hershman DL, ASCO Annual Meeting, Chicago, IL, 5/2015
Trends and safety of image-guided percutaneous pleural biopsies in cancer patients
Accordino MK, Wright JD, Shim J, Neugut AI, Hillyer G, Hershman DL, ASCO Annual Meeting, Chicago, IL, 5/1/2014

Press Mentions

Addressing Opioid Misuse in Cancer Pain ManagementJune 4th, 2022
Research Ramps up After Pause for PandemicSeptember 4th, 2020

Grant Support

Cancer-Related Population Sciences R25 Postdoctoral FellowshipNational Cancer Institute2014–2015
ASCO Young Investigator AwardConquer Cancer Foundation of ASCO2014–2015

Committees

Member, Division of Hematology/Oncology Quality and Patient Safety Committee 2014 - Present
Member, Division of Hematology/Oncology Quality and Patient Safety Committee 2013 - Present